Obsession explained: What is heightmaxxing? New trend pushing teenagers to take cancer drugs to get taller? Why?
The 'heightmaxxing' trend is pushing some teenagers towards erdafitinib, a prescription cancer drug, in the hope of growing taller. But research cited by users involved only two children undergoing cancer treatment, and the medicine is not approved for height enhancement.
A new social media trend dubbed "heightmaxxing" has teenagers considering taking a prescription cancer drug, erdafitinib, in hopes of growing taller. This offshoot of the broader "maxxing" culture involves young people seeking to optimize their ideal physical selves. Erdafitinib, typically used to treat certain adult cancers, has reportedly led to unexpected growth spurts in children during treatment, fueling interest among teens.
However, the drug is not approved for height enhancement and its long-term effects in healthy teenagers are unknown. Zak, a 17-year-old TikTok user, began taking erdafitinib at 15 and experienced side effects like nosebleeds, dry skin, and joint pain. Despite stopping the drug, Zak believes he grew several inches between ages 15 and 17.
Experts warn that interfering with bone growth processes in healthy children could have unknown long-term consequences, and pediatric endocrinologists advise against using erdafitinib for height purposes.
Written by urgent.news from Live Mint's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
